Literature DB >> 15170474

CLC-K channels: if the drug fits, use it.

Peying Fong1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170474      PMCID: PMC1299078          DOI: 10.1038/sj.embor.7400168

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  12 in total

1.  X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity.

Authors:  Raimund Dutzler; Ernest B Campbell; Martine Cadene; Brian T Chait; Roderick MacKinnon
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

Review 2.  Molecular structure and physiological function of chloride channels.

Authors:  Thomas J Jentsch; Valentin Stein; Frank Weinreich; Anselm A Zdebik
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

3.  Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure.

Authors:  R Birkenhäger; E Otto; M J Schürmann; M Vollmer; E M Ruf; I Maier-Lutz; F Beekmann; A Fekete; H Omran; D Feldmann; D V Milford; N Jeck; M Konrad; D Landau; N V Knoers; C Antignac; R Sudbrak; A Kispert; F Hildebrandt
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

4.  Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.

Authors:  R Estévez; T Boettger; V Stein; R Birkenhäger; E Otto; F Hildebrandt; T J Jentsch
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

5.  Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney.

Authors:  Katsuki Kobayashi; Shinichi Uchida; Shuki Mizutani; Sei Sasaki; Fumiaki Marumo
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

6.  Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.

Authors:  Antonella Liantonio; Michael Pusch; Alessandra Picollo; Patrizia Guida; Annamaria De Luca; Sabata Pierno; Giuseppe Fracchiolla; Fulvio Loiodice; Paolo Tortorella; Diana Conte Camerino
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

7.  Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.

Authors:  Y Matsumura; S Uchida; Y Kondo; H Miyazaki; S B Ko; A Hayama; T Morimoto; W Liu; M Arisawa; S Sasaki; F Marumo
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

8.  Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.

Authors:  Alessandra Picollo; Antonella Liantonio; Maria Paola Didonna; Laura Elia; Diana Conte Camerino; Michael Pusch
Journal:  EMBO Rep       Date:  2004-05-28       Impact factor: 8.807

9.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.

Authors:  Antonella Liantonio; Alessio Accardi; Giuseppe Carbonara; Giuseppe Fracchiolla; Fulvio Loiodice; Paolo Tortorella; Sonia Traverso; Patrizia Guida; Sabata Pierno; Annamaria De Luca; Diana Conte Camerino; Michael Pusch
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

10.  Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1.

Authors:  Raúl Estévez; Björn C Schroeder; Alessio Accardi; Thomas J Jentsch; Michael Pusch
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

View more
  8 in total

1.  Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.

Authors:  G Zifarelli; A Liantonio; A Gradogna; A Picollo; G Gramegna; M De Bellis; A R Murgia; E Babini; D Conte Camerino; M Pusch
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Novel diuretic targets.

Authors:  Jerod S Denton; Alan C Pao; Merritt Maduke
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

3.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.

Authors:  Antonella Liantonio; Alessandra Picollo; Giuseppe Carbonara; Giuseppe Fracchiolla; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza; Elena Babini; Giovanni Zifarelli; Michael Pusch; Diana Conte Camerino
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

4.  Discovery of potent CLC chloride channel inhibitors.

Authors:  Kimberly Matulef; Andrew E Howery; Li Tan; William R Kobertz; J Du Bois; Merritt Maduke
Journal:  ACS Chem Biol       Date:  2008-07-18       Impact factor: 5.100

5.  Molecular Pharmacology of Kidney and Inner Ear CLC-K Chloride Channels.

Authors:  Antonella Gradogna; Michael Pusch
Journal:  Front Pharmacol       Date:  2010-10-25       Impact factor: 5.810

6.  Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka.

Authors:  Andrea Gerbino; Roberta De Zio; Daniela Russo; Luigi Milella; Serena Milano; Giuseppe Procino; Michael Pusch; Maria Svelto; Monica Carmosino
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

Review 7.  Regulatory-auxiliary subunits of CLC chloride channel-transport proteins.

Authors:  Alejandro Barrallo-Gimeno; Antonella Gradogna; Ilaria Zanardi; Michael Pusch; Raúl Estévez
Journal:  J Physiol       Date:  2015-09-15       Impact factor: 5.182

8.  Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.

Authors:  Alessandra Picollo; Antonella Liantonio; Elena Babini; Diana Conte Camerino; Michael Pusch
Journal:  J Membr Biol       Date:  2007-07-21       Impact factor: 1.843

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.